miR-486-5p diagnosed atrial fibrillation, predicted the risk of left atrial fibrosis, and regulated angiotensin II-induced cardiac fibrosis via modulating PI3K/Akt signaling through targeting FOXO1
Authors:
- 23 May 2024
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (2) , 1077-1087
Abstract
This study focused on miR-486-5p in atrial fibrillation (AF) evaluating its clinical significance and revealing its regulatory mechanism in cardiac fibroblasts, aiming to explore a novel biomarker for AF. The study enrolled 131 AF patients and 77 non-AF individuals. With the help of polymerase chain reaction (PCR), the expression of miR-486-5p was evaluated. The significance of miR-486-5p in the diagnosis of AF and the occurrence of left atrial fibrosis (LAF) was assessed by receiver operating curve (ROC) and logistic analyses. The regulatory effect and mechanism of miR-486-5p on cardiac fibrosis were investigated in human cardiac fibroblasts treated with angiotensin II. miR-486-5p was significantly upregulated in AF patients and discriminated AF patients from non-AF individuals. Increasing miR-486-5p showed a significant association with decreasing left ventricular ejection fraction (LVEF), increasing left atrial diameter (LAD) and left ventricular end-diastolic diameter (LVEDd), and the high incidence of LAF in AF patients. Moreover, miR-486-5p was identified as a risk factor for LAF and could distinguish AF patients with LAF and without LAF. In cardiac fibroblasts, angiotensin II induced the upregulation of miR-486-5p and promoted cell proliferation, migration, and collagen synthesis. miR-486-5p negatively regulated forkhead box O1 (FOXO1) and its knockdown could reverse the promoted effect of angiotensin II. FOXO1 alleviated the effect of miR-486-5p, and the miR-486-5p/FOXO1 could activate PI3K/Akt signaling. The activation of PI3K/Akt signaling alleviated the enhanced proliferation, migration, and collagen synthesis of cardiac fibroblasts induced by angiotensin II, and its inhibition showed opposite effects. Increased miR-486-5p served as a biomarker for the diagnosis and development prediction of AF. miR-486-5p regulated cardiac fibroblast viability and collagen synthesis via modulating the PI3K/Akt signaling through targeting FOXO1.Keywords
This publication has 53 references indexed in Scilit:
- MicroRNA in Control of Gene Expression: An Overview of Nuclear FunctionsInternational Journal of Molecular Sciences, 2016
- Co-circulation of the dengue with chikungunya virus during the 2013 outbreak in the southern part of Lao PDRTropical Medicine and Health, 2016
- Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2016
- Posttranslational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failureAtherosclerosis, 2016
- Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosisNature Reviews Cardiology, 2016
- Atrial Fibrillation: Pathophysiology and Therapeutic OptionsJournal of Cardiothoracic and Vascular Anesthesia, 2015
- FOXO1 Transcription Factor: A Critical Effector of the PI3K-AKT Axis in B-Cell DevelopmentInternational Reviews of Immunology, 2014
- Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial InfarctionPLOS ONE, 2012
- The Role of miRNA in Stem Cell Pluripotency and Commitment to the Vascular Endothelial LineageMicrocirculation, 2012
- Prognosis in atrial fibrillationThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006